Effect of Calcium Blocking Agent Verapamil on Blood Pressure, Ventricular Contractility, Parathyroid Hormone, Calcium and Phosphorus in Plasma, Catecholamines, Corticosterone and Plasma Renin Activity in Spontaneously Hypertensive Rats

References

• Subramanian Bala, Lahiri A., Paramasivan R., Raftery E. Verapamil in chronic stable angina. Lancet 1980; 1: 841–844
   PubMed Web of Science ®Google Scholar
• Singh B., Ellrodt Peter C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 1978; 15: 169–197
   PubMed Web of Science ®Google Scholar
• Bühler F., Hulthen U., Kiouiski W., Muller F., Bolli P. The phase of calcium antagonist verapamil in antihypertensive therapy. J. Cardiovasc. Pharmacol. 1982; 4(Suppl. 3)S350–S357
   PubMedGoogle Scholar
• Midtbo K., Hals O., van der Meer J. Verapamil compared with nifedipine in the treatment of essential hypertension. J. Cardiovasc. Pharmac. 1982; S363–S368, v. J. Suppl. 3
   Google Scholar
• Muiesan G., Agabiti-Rosei E., Castellano M., Alicandri C., Corea L., Fariello R., Beschi M. G. Romanelli. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension. J. Cardiovasc. Pharmacol. 1982; v.4(Suppl. 3)S325–S329
   Google Scholar
• Pernot F., Berthelot A., Gairard A. Sodium balance, parathyroidectomy and the development of hypertension in spontaneously hypertensive and DOCA-salt rats. Hypertensive Mechanisms, W. Rascher, D. Clough, D. Ganten, Stuttgart-New York 1981; 641–645
   Google Scholar
• Anderson S., Ellison D., McCarron D. Administration of synthetic human (1–34) parathyroid hormone in the spontaneously hypertensive rat. Hypertensive Mechanisms, W. Rascher, D. Clough, D. Ganten, Stuttgart-New York 1981; 646–649
   Google Scholar
• DeVito W., Sutterer J., Brush F. The pituitary-adrenal response to ether in the spontaneously hypertensive and normotensive rats. Life sci. 1981; 28: 1489–1495
   PubMed Web of Science ®Google Scholar
• DeLeeuw P., Blick W., Vanes P. N. Effet des inhibiteurs calcique sur l'activité sympathique. Arch. Mal. Coeur Vaise 1985; 51–54, 78/spec. No
   Google Scholar
• Hiramatsu K., Yamagishi F., Kubota T., Yamada T. Acute effect of calcium antagonist nifedipine on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in patients with essential hypertension. Amer. Heart J. 1982; 104: 1346
   PubMed Web of Science ®Google Scholar
• Hulthen U., Bolli P., Amann F., Kiowski W., Buhler F. Verapamil induced vasodilatation is enhanced in essential hypertension. J. Cardiovasc. Pharm. 1982; 4(Suppl. 3)S313–S318
   PubMedGoogle Scholar
• Ancov V., Kolebinov N., Jelev N., Shuleva M. Spectrofluorometric determination of plasma 11-hydrocorticosteroids in normal individual and dogs. Savr. Med. 1970; 21: 23–28, (In Bulgarian)
   Google Scholar
• Grout J. R. Standard methods in clinical chemistry. Acad. Press, New York 1961; vol. 3, 62.80
   Google Scholar
• Lederballe O., Mikkelsen E., Jespsrsen L. Treatment with verapamil reduces blood pressure and tends to normalize vascular responsiveness and ion transport in the spontaneously hypertensive rat. J. Cardiovasc. Pharm. 1982; 4(Suppl. 3)S294–S297
   PubMedGoogle Scholar
• Pollack G. Maximum velocity as an index of contractility in cardiac muscle. A critical evaluation. Circ. Res. 1970; 26: 111–127
   PubMed Web of Science ®Google Scholar
• Braunwald E., Ross J., Sonnenblick E. Mechanisms of contraction of the normal and failing heart, B. Shargorodski. Medicina, Moskva 1974, (in Russian)
   Google Scholar
• Markov Ch., Rosenberg A., Pinelis V. Calcium metabolism in vessels and heart of spontaneously hypertensive rats. Cardiol. 1982; v. 22(12)66–71
   Google Scholar
• Merzon K. The effect of verapamil and nifedipine on serum calcium. Cardiol. 1985; v. 25(7)89–93, (In Russian)
   Google Scholar
• Wright G., Toraason M., Barbe J., Grouse W. The concentrations of ionic and total calcium in plasma of the spontaneously hypertensive rat. Can. J. Physiol. Pharmacol. 1980; v. 58: 1494–1499
   Web of Science ®Google Scholar
• McCarron D., Yung N., Ugorets B., Krutzik S. Disturbances of calcium metabolism in the spontaneously hypertensive rats. Hypertension 1981; 3(Suppl. 1)162–167
   Google Scholar
• Postnov J., Orlov S. Primary hypertension as a pathology of cell membranes. Cardiol. 1983; v. 23(12)5–12, (In Russian)
   Google Scholar
• Lethonen A., Gordin A. Metabolic parameters after changing fromhydrochlorthiazide to verapamil treatment in hypertension. Eur. J. Clin. Pharm. 1984; 27: 153–157
   PubMed Web of Science ®Google Scholar
• Shamoon H., Baylor P., Kambosos D. Influence of oral verapamil on glucoregulatory hormones in man. J. Clin. Endocrinol. Metabol. 1985; 60/3: 536–541
   Web of Science ®Google Scholar
• Nayler W., Sturrock W. An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from the ischemic and reperfused hearts. J. Mol. Cell. Cardiol. 1984; 16/4: 331–343
   Web of Science ®Google Scholar
• Chaudhry A., Vochra M. M. A reserpine-like action of verapamil on cardiac sympathetic nerves. Eur. J. Pharmacol. 1984; 97: 156–158
   PubMed Web of Science ®Google Scholar
• Fleckenstein A., Janke J., Doring H., Pachinger O. Calcium overload as the determinant factor in the production of catecholamine induced myocardial lesions. Recent advances in Studies on Cardiac Structure and Metabolism, E. Bajuse, J. Rona. University Park Press, Baltimore 1974; Vol. 2: 455–466, Cardiomyopathies
   Google Scholar
• Fleckenstein A., Janke J., Daring H., Leder O. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology. Recent advances in studies on Cardiac Structure and Metabolism, N. S. Dhalla. University Park Prass, Baltimore 1979; vol.4: 563–580, Myocardial Biology
   Google Scholar
• Zofkova I., Blahos J., Neradilova M. Verapamil increases adrenocortical secretory reserve. Exp. Clin. Endocrin. 1983; v.82(1)101–103
   Google Scholar
• Fuxe K., Agnati L., Ganten D., Andersson K., Calsa L., Vincent M., Sassard J., Yukimura T., Eneroth P., Goldstein M., Hökfelt T., Rosell S., Härfstrand A., Vale W., Braun M., Rivier J. Central and peripheral hormones and peptides. Hypertensive Mechanisms, W. Rascher, D. Clough, D. Ganten, Stuttgart-New York 1981; 417–442
   Google Scholar
• Petkova M., Ilieva T., Popova N. N., Nicolov A., Tzoncheva, Grigorova R. Changes in corticosterone, epinephrine and norepinephrine in spontaneously hypertensive rats exposed to captopril treatment. Neurosciences 1986; 12: 245–252
   Google Scholar
• Leonetti G., Cuspidi C., Sampieri L., Tezzoli L., Zanchetti A. Comparison of cardiovascular, Renal and hormonal effects on acute administration of two calcium channel blockers in normotensive and hypertensive subjects. J. Cardiovasc. Pharmacol. 1982; v.4(Suppl.3)S319–S324
   Google Scholar
• Halperin A., Cubeddu L. The role of calcium channel blockers in the treatment of hypertension. Amer. Heart J. 1986; 111(2)363–382
   PubMed Web of Science ®Google Scholar
• Nadler J., Hsueh W., Horton R. Therapeutic effect of calcium channel blockade in primary aldosteronism. J. Clin. Endocrin. Metabol. 1985; 60/5: 896–899
   Web of Science ®Google Scholar
• Robinson B. F. Calcium-entry blocking agents in the treatment of systemic hypertension. Amer. J. Cardiol. 1985; 55/3: 102B–106B
   Web of Science ®Google Scholar